Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Psybio Therapeutics Corp (OP: PSYBF ) 0.0001 UNCHANGED Streaming Delayed Price Updated: 9:49 AM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Psybio Therapeutics Corp MA, FL And OH Psychedelics Scientists And Educators' Latest Research And Views June 08, 2023 Along with a growing scientific corpus supporting the therapeutic potential of psychedelics, several states and most noticeably Massachusetts are seeing the decriminalization of natural substances... Via Benzinga EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key' April 14, 2023 Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental... Via Benzinga Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More December 13, 2022 Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers Via Benzinga Psychedelics & Environmental Protection: Company Seeks Patents To Synthetically Produce Toad Venom December 12, 2022 Psychedelic therapeutics biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed three additional U.S. Via Benzinga Psychedelics Production Methods Expect Further IP Protection With 4 New Patents December 07, 2022 Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications aiming to convert five provisional patent applications. Via Benzinga Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project December 06, 2022 Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... Via Benzinga PsyBio Therapeutics Reports Interim Third Quarter 2022 Financial Results December 01, 2022 PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) reported its unaudited interim financial results for the three and nine-month period ended September 30, 2022. Via Benzinga Yeast Produces Bread And Psilocybin, This Company Is Moving Into Clinical Trial Phase October 11, 2022 The current clinical scenario sets psilocybin as one of the most advanced psychedelics, expected to become legally approved in the US sometime between the 2023-2024 period and to become available as of... Via Benzinga Most, But Not All, Psychedelics Companies Have Sufficient Liquidity September 06, 2022 The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database. Via Benzinga DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results August 29, 2022 PsyBio Therapeutics (TSXV: PSYB) (OTCQB: PSYBF), a biotech developing medicines based on naturally-occurring psychedelic substances, and mushroom producer Red Light Holland Corp. (OTC Pink: TRUFF)... Via Benzinga PsyBio Therapeutics Presents "How Genetically Modified Bacteria Can Yield Best-In-Class Psychedelics" At The Psychedelic Capital Conference April 29, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Cannabis Movers & Shakers: Burns & Levinson, Water Ways, Chill Brands, Rubicon Organics January 24, 2022 Burns & Levinson Expands National Cannabis Business Law Practice Boston-based Burns & Levinson LLP annou... Via Benzinga Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study September 27, 2021 The Week In Psychedelics: Via Benzinga Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies July 02, 2021 Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o... Via Benzinga Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More June 30, 2021 Institutional analysts are taking a liking to the industry ... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
